FDA Briefing Package for Alefacept BLA125036/0

ERRATA

Page 4, paragraph 3, line 2, change to: "The product is stored at room temperature."

Page 21, paragraph 1 line 4, change to: "Questions arose about the reliability of potency assay and have been resolved"

Page 50, paragraph 6, lines 4, change to: "…score ranges from 0 (best) to 30 (worst)"

Page 73, next-to-last line, change to: "… the differences in mean change favor alefacept and are approximately 3 points for DLQI and range from 3 to 10 points for DQOLS."

Page 103, line 4, change to "… this represents a 3 point improvement in the score."

Page 103, line 7, change to"(ranged from 4 to 9 point improvement)."